HVSEN Biotechnology Co., Ltd. (300871) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

HVSEN Biotechnology Co., Ltd.

Why is HVSEN Biotechnology Co., Ltd. ?

With a growth in Net Sales of 3.36%, the company declared Outstanding results in Sep 25

The company has declared positive results for the last 2 consecutive quarters
INTEREST COVERAGE RATIO(Q) The company hardly has any interest cost
OPERATING CASH FLOW(Y) Highest at CNY 223.68 MM
ROCE(HY) Highest at 12.2%

With ROE of 5.81%, it has a attractive valuation with a 2.03 Price to Book Value

Over the past year, while the stock has generated a return of 60.15%, its profits have risen by 1250.6% ; the PEG ratio of the company is 0
At the current price, the company has a high dividend yield of 0.8

Market Beating performance in long term as well as near term

Along with generating 60.15% returns in the last 1 year, the stock has outperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you buy?

Overall Portfolio exposure to HVSEN Biotechnology Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is HVSEN Biotechnology Co., Ltd. for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

HVSEN Biotechnology Co., Ltd.

31.89%

1.70

73.49%

China Shanghai Composite

15.17%

1.02

14.86%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

20.54%

EBIT Growth (5y)

9.05%

EBIT to Interest (avg)

28.86

Debt to EBITDA (avg)

2.06

Net Debt to Equity (avg)

0.32

Sales to Capital Employed (avg)

0.47

Tax Ratio

4.26%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

6.28%

ROE (avg)

4.83%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.03

EV to EBIT

30.07

EV to EBITDA

16.39

EV to Capital Employed

2.01

EV to Sales

2.68

PEG Ratio

0.03

Dividend Yield

0.82%

ROCE (Latest)

6.70%

ROE (Latest)

5.81%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Bullish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Bullish

Dow Theory

Mildly Bearish

Mildly Bullish

OBV

Mildly Bullish

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

34What is working for the Company

INTEREST COVERAGE RATIO(Q)

The company hardly has any interest cost

OPERATING CASH FLOW(Y)

Highest at CNY 223.68 MM

ROCE(HY)

Highest at 12.2%

PRE-TAX PROFIT(Q)

At CNY 82.13 MM has Grown at 140.78%

NET PROFIT(Q)

At CNY 71.7 MM has Grown at 141.42%

RAW MATERIAL COST(Y)

Fallen by -202.86% (YoY

DEBT-EQUITY RATIO (HY)

Lowest at -2.17 %

INVENTORY TURNOVER RATIO(HY)

Highest at 4.97 times

DEBTORS TURNOVER RATIO(HY)

Highest at 3.66 times

NET SALES(Q)

Highest at CNY 437.33 MM

-2What is not working for the Company

NO KEY NEGATIVE TRIGGERS

Here's what is working for HVSEN Biotechnology Co., Ltd.

Pre-Tax Profit

At CNY 82.13 MM has Grown at 140.78%

over average net sales of the previous four periods of CNY 34.11 MM

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Net Profit

At CNY 71.7 MM has Grown at 141.42%

over average net sales of the previous four periods of CNY 29.7 MM

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CNY MM)

Operating Cash Flow

Highest at CNY 223.68 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Net Sales

Highest at CNY 437.33 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (CNY MM)

Debt-Equity Ratio

Lowest at -2.17 %

in the last five Semi-Annual periods

MOJO Watch

The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Inventory Turnover Ratio

Highest at 4.97 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio

Highest at 3.66 times

in the last five Semi-Annual periods

MOJO Watch

Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Raw Material Cost

Fallen by -202.86% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales